Jonathan L.
- Country
- France
- Department
- Médecine interne et rhumatologie
Research Overview
- Rituximab Maintenance Therapy versus Placebo in Patients with Stabilized Systemic Sclerosis–Associated Interstitial Lung Disease after Induction
- Evaluation of Rituximab-Based Combination, Tocilizumab, and Tofacitinib in Granulomatosis with Polyangiitis Patients Unresponsive to Standard Therapy
- Efficacy and Safety of Itacitinib in Adults with Diffuse Systemic Sclerosis: A Phase II Randomized Controlled Trial
Data & Insights
Has run more than one trial at 30 of 50 partner sites.
Specializations
Autoimmune Disorders
Specializes in investigating innovative treatments for complex autoimmune conditions, with particular focus on systemic sclerosis and granulomatosis with polyangiitis.
- Skin Fibrosis Management
- Diffuse Systemic Sclerosis Treatment
- Vasculitis Therapy
Conducts research on novel therapeutic approaches for patients with challenging autoimmune manifestations.
Therapeutic Innovation
Explores advanced treatment strategies using targeted immunomodulatory therapies including JAK inhibitors and biologic agents.
- Novel Drug Applications
- Treatment-Resistant Conditions
- Combination Therapy Approaches
Evaluates alternative therapeutic options for patients with inadequate response to conventional treatments.
Clinical Assessment
Focuses on evaluating treatment outcomes through specialized clinical measurements including modified Rodnan skin scoring and other disease activity assessments.
- Disease Activity Monitoring
- Treatment Response Evaluation
- Long-term Outcome Assessment
Implements systematic approaches to measure therapeutic efficacy in complex rheumatic conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.